Opus Genetics (IRD) News Today $1.09 -0.02 (-1.80%) Closing price 02/21/2025 03:59 PM EasternExtended Trading$1.14 +0.05 (+4.59%) As of 02/21/2025 06:24 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period Opus Genetics, Inc.: Opus Genetics Announces Updates on OPGx-LCA5 Clinical ProgramFebruary 19 at 9:51 AM | finanznachrichten.deAnalysts Offer Insights on Healthcare Companies: Opus Genetics (IRD), Tactile Systems Technology (TCMD) and Insmed (INSM)February 19 at 9:51 AM | markets.businessinsider.comOpus Genetics provides update on OPGx-LCA5 clinical programFebruary 19 at 4:49 AM | markets.businessinsider.comOpus Genetics Announces Updates on OPGx-LCA5 Clinical ProgramFebruary 18, 2025 | globenewswire.comShareholder Group Led by Founder Mina Sooch Nominates Majority Slate of Director Candidates to the Board of Opus Genetics, Inc.February 7, 2025 | globenewswire.comOpus Genetics revises executive compensation agreementsJanuary 24, 2025 | msn.comOpus Genetics Enhances Executive Severance PackagesJanuary 24, 2025 | tipranks.comInsider Buying: Opus Genetics, Inc. (NASDAQ:IRD) CEO Purchases 100,000 Shares of StockDecember 31, 2024 | insidertrades.comBuy Rating for Opus Genetics: Strategic FDA Agreement and APX3330’s Market PotentialDecember 20, 2024 | markets.businessinsider.comOpus Genetics, Inc.: Opus Genetics Receives FDA Agreement Under Special Protocol Assessment for Phase 3 Trial of APX3330 in Diabetic RetinopathyDecember 19, 2024 | finanznachrichten.deOpus Genetics receives FDA agreement under SPA for Phase 3 trial of APX3330December 19, 2024 | markets.businessinsider.comOpus Genetics Receives FDA Agreement Under Special Protocol Assessment for Phase 3 Trial of APX3330 in Diabetic RetinopathyDecember 19, 2024 | globenewswire.comBuy Rating Affirmed for Opus Genetics Amid Promising OPGx-LCA5 Treatment Results and Regulatory ProgressDecember 17, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Opus Genetics (IRD) and Brainstorm Cell Therapeutics (BCLI)December 15, 2024 | markets.businessinsider.comInsider Buying: Opus Genetics, Inc. (NASDAQ:IRD) CEO Acquires 90,294 Shares of StockNovember 20, 2024 | insidertrades.comOpus Genetics, Inc. (IRD)November 15, 2024 | ca.finance.yahoo.com Get Opus Genetics News Delivered to You Automatically Sign up to receive the latest news and ratings for IRD and its competitors with MarketBeat's FREE daily newsletter. Email Address IRD Media Mentions By Week IRD Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IRD News Sentiment▼0.000.60▲Average Medical News Sentiment IRD News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IRD Articles This Week▼51▲IRD Articles Average Week Get Opus Genetics News Delivered to You Automatically Sign up to receive the latest news and ratings for IRD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Seres Therapeutics News Puma Biotechnology News Coherus BioSciences News Biomea Fusion News Black Diamond Therapeutics News Cabaletta Bio News 2seventy bio News Kyverna Therapeutics News Sagimet Biosciences News Inventiva News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:IRD) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | Sponsored[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIEDRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredWhat is this southern state hiding?The financial press had a field day this week after President Donald Trump and Department of Government Effici...Stansberry Research | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Opus Genetics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Opus Genetics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IRD Stock Alerts